The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global biomaterials market reached a value of US$ 91.23 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 182.11 Billion by 2027, exhibiting a CAGR of 11.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
A biomaterial refers to a matter, surface or construct that can be obtained from nature or manufactured in the laboratory using polymers, metallic components, ceramics or composite materials. It interacts with biological systems and assists in restoring different functions and facilitating healing among individuals after an injury or a disease. Consequently, it finds extensive applications in neurology, cardiology, orthopedics, ophthalmology, wound care, dentistry, and plastic surgery across the globe.
There is an increase in the number of individuals with musculoskeletal conditions around the world. This, in confluence with the rising geriatric population, represents one of the key factors impelling the growth of the market. Moreover, biomaterials are used in medical implants, including heart valves, stents, grafts, artificial joints, ligaments, tendons, hearing loss and dental implants, and devices that stimulate nerves. They are also utilized in dissolvable dressings and sutures, clips, and staples for wound closure. In addition, biomaterials aid in cardiac repair and regeneration as a carrier for drug delivery or as an extracellular matrix substitute scaffold. This, along with the burgeoning healthcare industry, is catalyzing the demand for biomaterials worldwide. Apart from this, advancements in molecular self-assembly, polymer synthesis, protein and peptide engineering, and microfabrication technologies have resulted in the introduction of next-generation smart biomaterials. These biomaterials can adapt their chemical and mechanical properties according to changes in physiological parameters and exogenous stimuli. This, coupled with the increasing focus of market players on product innovations to offer better services to end users, is positively influencing the market. Other factors strengthening the growth of the market include the rising prevalence of cardiovascular diseases and the increasing awareness among the masses about the advantages of biomaterials.
IMARC Group provides an analysis of the key trends in each sub-segment of the global biomaterials market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type and application.
Breakup by Type:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Berkeley Advanced Biomaterials, Carpenter Technology Corporation, Collagen Matrix Inc., CoorsTek Inc., Corbion N.V., Dentsply Sirona, Evonik Industries AG, Johnson & Johnson, Koninklijke DSM N.V., Medtronic plc, Stryker Corporation, Victrex plc and Zimmer Biomet.
|Base Year of the Analysis||2021|
|Segment Coverage||Type, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||BASF SE, Berkeley Advanced Biomaterials, Carpenter Technology Corporation, Collagen Matrix Inc., CoorsTek Inc., Corbion N.V., Dentsply Sirona, Evonik Industries AG, Johnson & Johnson, Koninklijke DSM N.V., Medtronic plc, Stryker Corporation, Victrex plc and Zimmer Biomet.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at